Biopac India Corporation Limited announced audited standalone earnings results for the fourth quarter and full year ended March 31, 2018. For the quarter, the company reported revenue from operations (net of excise duty) of INR 110.800 million against INR 138.765 million for the same period in the last year. Total income from operations (net) was INR 110.809 million against INR 138.768 million for the same period in the last year. Loss from operations before exceptional items and tax was INR 36.700 million against profit from operations before exceptional items and tax of INR 0.330 million for the same period in the last year. Loss before tax was INR 36.700 million against profit before tax of INR 0.330 million for the same period in the last year. Net loss after tax was INR 32.803 million against INR 0.489 million for the same period in the last year. Basic and diluted loss per share was INR 1.90 against INR 0.03 for the same period in the last year. For the year, the company reported revenue from operations (net of excise duty) of INR 472.097 against INR 477.723 million for the same period in the last year. Total income from operations (net) was INR 472.116 million against INR 477.757 million for the same period in the last year. Loss from operations before exceptional items and tax was INR 30.219 million against profit from operations before exceptional items and tax of INR 2.799 million for the same period in the last year. Loss before tax was INR 30.219 million against profit before tax of INR 2.799 million for the same period in the last year. Net loss after tax was INR 27.000 million against net profit after tax of INR 0.983 million for the same period in the last year. Basic and diluted loss per share was INR 1.57 against basic and diluted earnings per share of INR 0.06 for the same period in the last year.